Annual Total Debt
$1.10 M
-$46.58 M-97.70%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual total debt is $1.10 million, with the most recent change of -$46.58 million (-97.70%) on December 31, 2022.
- During the last 3 years, LMNL annual total debt has fallen by -$34.94 million (-96.96%).
Performance
LMNL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Debt
$910.80 K
-$92.40 K-9.21%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly total debt is $910.80 thousand, with the most recent change of -$92.40 thousand (-9.21%) on June 30, 2023.
- Over the past year, LMNL quarterly total debt has dropped by -$17.03 million (-94.92%).
Performance
LMNL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
LMNL Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.7% | -94.9% |
| 3 y3 years | -97.0% | -97.3% |
| 5 y5 years | -98.5% | -99.1% |
LMNL Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.7% | at low | -98.1% | at low |
| 5 y | 5-year | -98.1% | at low | -98.4% | at low |
| alltime | all time | -98.9% | -100.0% | -99.4% | -100.0% |
Liminal BioSciences Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $910.80 K(-9.2%) |
| Mar 2023 | - | $1.00 M(-8.4%) |
| Dec 2022 | $1.10 M(-97.7%) | $1.10 M(-4.2%) |
| Sep 2022 | - | $1.14 M(-93.6%) |
| Jun 2022 | - | $17.94 M(-1.4%) |
| Mar 2022 | - | $18.20 M(-61.8%) |
| Dec 2021 | $47.67 M(-17.8%) | $47.67 M(-3.7%) |
| Sep 2021 | - | $49.52 M(-6.8%) |
| Jun 2021 | - | $53.14 M(-6.1%) |
| Mar 2021 | - | $56.59 M(-2.5%) |
| Dec 2020 | $58.02 M(+61.0%) | $58.02 M(+3.0%) |
| Sep 2020 | - | $56.36 M(+67.2%) |
| Jun 2020 | - | $33.71 M(+5.5%) |
| Mar 2020 | - | $31.96 M(-11.3%) |
| Dec 2019 | $36.03 M(-63.2%) | $36.03 M(-8.2%) |
| Sep 2019 | - | $39.25 M(+2.4%) |
| Jun 2019 | - | $38.33 M(-73.0%) |
| Mar 2019 | - | $141.82 M(+44.7%) |
| Dec 2018 | $98.01 M(+33.4%) | $98.01 M(-19.3%) |
| Sep 2018 | - | $121.41 M(+24.9%) |
| Jun 2018 | - | $97.17 M(+9.8%) |
| Mar 2018 | - | $88.50 M(+20.5%) |
| Dec 2017 | $73.47 M(+97.6%) | $73.47 M(+31.7%) |
| Sep 2017 | - | $55.80 M(+2.4%) |
| Jun 2017 | - | $54.49 M(+41.5%) |
| Mar 2017 | - | $38.50 M(+3.6%) |
| Dec 2016 | $37.18 M(+123.7%) | $37.18 M(+15.6%) |
| Sep 2016 | - | $32.15 M(+1.7%) |
| Jun 2016 | - | $31.62 M(-3.9%) |
| Mar 2016 | - | $32.92 M(+98.1%) |
| Dec 2015 | $16.62 M(-19.0%) | $16.62 M(+1.2%) |
| Sep 2015 | - | $16.42 M(-5.2%) |
| Jun 2015 | - | $17.32 M(-4.8%) |
| Mar 2015 | - | $18.19 M(-11.3%) |
| Dec 2014 | $20.51 M(+130.3%) | $20.51 M(+1.0%) |
| Sep 2014 | - | $20.30 M(+107.3%) |
| Jun 2014 | - | $9.79 M(+9.2%) |
| Mar 2014 | - | $8.97 M(+0.7%) |
| Dec 2013 | $8.90 M(-4.4%) | $8.90 M(-28.2%) |
| Sep 2013 | - | $12.41 M(+105.2%) |
| Jun 2013 | - | $6.05 M(-18.0%) |
| Mar 2013 | - | $7.38 M(-20.8%) |
| Dec 2012 | $9.32 M(+20.7%) | $9.32 M(+305.5%) |
| Sep 2012 | - | $2.30 M(-62.6%) |
| Jun 2012 | - | $6.14 M(-0.5%) |
| Mar 2012 | - | $6.17 M(-20.1%) |
| Dec 2011 | $7.72 M(-46.4%) | $7.72 M(+331.2%) |
| Sep 2011 | - | $1.79 M(-60.8%) |
| Jun 2011 | - | $4.57 M(+23.2%) |
| Mar 2011 | - | $3.71 M(-74.3%) |
| Dec 2010 | $14.41 M | $14.41 M(+7.1%) |
| Sep 2010 | - | $13.46 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $13.53 M(-12.3%) |
| Mar 2010 | - | $15.42 M(+156.1%) |
| Dec 2009 | $6.02 M(+52.6%) | $6.02 M(+62.7%) |
| Sep 2009 | - | $3.70 M(-10.5%) |
| Jun 2009 | - | $4.14 M(-15.1%) |
| Mar 2009 | - | $4.87 M(+23.5%) |
| Dec 2008 | $3.94 M(-41.3%) | $3.94 M(-25.8%) |
| Sep 2008 | - | $5.31 M(-14.9%) |
| Jun 2008 | - | $6.24 M(-7.5%) |
| Mar 2008 | - | $6.75 M(+0.5%) |
| Dec 2007 | $6.72 M(-32.3%) | $6.72 M(-12.6%) |
| Sep 2007 | - | $7.69 M(-5.0%) |
| Jun 2007 | - | $8.09 M(-0.0%) |
| Mar 2007 | - | $8.09 M(-18.5%) |
| Dec 2006 | $9.93 M(+111.5%) | $9.93 M(+44.4%) |
| Sep 2006 | - | $6.87 M(-16.4%) |
| Jun 2006 | - | $8.22 M(+40.2%) |
| Mar 2006 | - | $5.86 M(+24.9%) |
| Dec 2005 | $4.69 M(+200.7%) | $4.69 M(+156.8%) |
| Sep 2005 | - | $1.83 M(-17.6%) |
| Jun 2005 | - | $2.22 M(+52.7%) |
| Mar 2005 | - | $1.45 M(-7.0%) |
| Dec 2004 | $1.56 M(+51.6%) | $1.56 M(+102.2%) |
| Sep 2004 | - | $772.10 K(-6.8%) |
| Jun 2004 | - | $828.60 K(-11.6%) |
| Mar 2004 | - | $937.10 K(-9.0%) |
| Dec 2003 | $1.03 M(+363.9%) | $1.03 M(+17.9%) |
| Sep 2003 | - | $873.00 K(-6.9%) |
| Jun 2003 | - | $938.20 K(+27.9%) |
| Mar 2003 | - | $733.60 K(+230.6%) |
| Dec 2002 | $221.90 K(>+9900.0%) | $221.90 K(-7.7%) |
| Sep 2002 | - | $240.40 K(-6.6%) |
| Jun 2002 | - | $257.30 K(>+9900.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2001 | - | $26.70 K(-33.7%) |
| Jun 2001 | - | $40.30 K(-27.5%) |
| Mar 2001 | - | $55.60 K(-24.7%) |
| Dec 2000 | $73.80 K(-92.3%) | $73.80 K(-46.2%) |
| Sep 2000 | - | $137.30 K(-32.2%) |
| Jun 2000 | - | $202.50 K(-1.9%) |
| Mar 2000 | - | $206.50 K(-78.5%) |
| Dec 1999 | $962.70 K(-85.4%) | $962.70 K(-32.7%) |
| Sep 1999 | - | $1.43 M(-83.6%) |
| Jun 1999 | - | $8.73 M(+9.8%) |
| Mar 1999 | - | $7.95 M(+20.7%) |
| Dec 1998 | $6.59 M(+106.9%) | $6.59 M(+73.1%) |
| Sep 1998 | - | $3.81 M(-7.0%) |
| Jun 1998 | - | $4.09 M(+14.2%) |
| Mar 1998 | - | $3.58 M(+31.7%) |
| Dec 1997 | - | $2.72 M |
| Sep 1997 | $3.19 M | - |
FAQ
- What is Liminal BioSciences annual total debt?
- What is the all time high annual total debt for Liminal BioSciences?
- What is Liminal BioSciences annual total debt year-on-year change?
- What is Liminal BioSciences quarterly total debt?
- What is the all time high quarterly total debt for Liminal BioSciences?
- What is Liminal BioSciences quarterly total debt year-on-year change?
What is Liminal BioSciences annual total debt?
The current annual total debt of LMNL is $1.10 M
What is the all time high annual total debt for Liminal BioSciences?
Liminal BioSciences all-time high annual total debt is $98.01 M
What is Liminal BioSciences annual total debt year-on-year change?
Over the past year, LMNL annual total debt has changed by -$46.58 M (-97.70%)
What is Liminal BioSciences quarterly total debt?
The current quarterly total debt of LMNL is $910.80 K
What is the all time high quarterly total debt for Liminal BioSciences?
Liminal BioSciences all-time high quarterly total debt is $141.82 M
What is Liminal BioSciences quarterly total debt year-on-year change?
Over the past year, LMNL quarterly total debt has changed by -$17.03 M (-94.92%)